Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver
| Autor: | Xuejun Liu, J. Brandon Parker, Alex Nie, Michael K. McMillian, Stewart Bryant, Anton Bittner, Jackson S. Wan, Mark D. Johnson, Lynn Yieh, Judy Herlich, Michael Kemmerer, Angelique Leone |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Lipopolysaccharides
Male medicine.medical_treatment Gene Expression Biology Biochemistry Rats Sprague-Dawley Biological pathway chemistry.chemical_compound Gene expression medicine Animals RNA Messenger Oligonucleotide Array Sequence Analysis Pharmacology Activator (genetics) Gene Expression Profiling Macrophages Zymosan Macrophage Activation Gene signature Rats Cell biology Cytokine Gene Expression Regulation Liver chemistry Cytokines Peroxisome Proliferators Tumor necrosis factor alpha Toxicogenomics |
| Zdroj: | Biochemical Pharmacology. 67:2141-2165 |
| ISSN: | 0006-2952 |
| Popis: | Macrophage activation contributes to adverse effects produced by a number of hepatotoxic compounds. Transcriptional profiles elicited by two macrophage activators, LPS and zymosan A, were compared to those produced by 100 paradigm compounds (mostly hepatotoxicants) using cDNA microarrays. Several hepatotoxicants previously reported to activate liver macrophages produced transcriptional responses similar to LPS and zymosan, and these were used to construct a gene signature profile for macrophage activators in the liver. Measurement of cytokine mRNAs in the same liver samples by RT–PCR independently confirmed that these compounds are associated with macrophage activation. In addition to expected effects on acute phase proteins and metabolic pathways that are regulated by LPS and inflammation, a strong induction was observed for many endoplasmic reticulum-associated stress/chaperone proteins. Additionally, many genes in our macrophage activator signature profile were well-characterized PPARα-induced genes which were repressed by macrophage activators. A shared gene signature profile for peroxisome proliferators was determined using a training set of clofibrate, WY 14643, diethylhexylphthalate, diisononylphthalate, perfluorodecanoic acid, perfluoroheptanoic acid, and perfluorooctanoic acid. The signature profile included macrophage activator-induced genes that were repressed by peroxisome proliferators. NSAIDs comprised an interesting pharmacological class in that some compounds, notably diflunisal, co-clustered with peroxisome proliferators whereas several others co-clustered with macrophage activators, possibly due to endotoxin exposure secondary to their adverse effects on the gastrointestinal system. While much of these data confirmed findings from the literature, the transcriptional patterns detected using this toxicogenomics approach showed relationships between genes and biological pathways requiring complex analysis to be discerned. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect